Product
131I-omburtamab
Aliases
131I-8H9
2 clinical trials
4 indications
Indication
NeuroblastomaIndication
Central Nervous System MetastasesIndication
Leptomeningeal MetastasesClinical trial
A Multicenter Phase 2/3 Trial of the Efficacy and Safety of Intracerebroventricular Radioimmunotherapy Using 131I-omburtamab for Neuroblastoma Central Nervous System/Leptomeningeal MetastasesStatus: Terminated, Estimated PCD: 2023-06-02